LeonaBio, Inc.·4

Jun 24, 6:28 PM ET

PICKERING GRANT 4

Research Summary

AI-generated summary

Updated

LeonaBio Director Grant Pickering Receives 28,000-Share Option Grant

What Happened Director Grant Pickering received a grant/award of 28,000 derivative shares (reported as transaction code A) on 2026-06-23. The filing shows a $0.00 acquisition price because this is an equity award (option) granted as compensation rather than an open‑market purchase. No immediate cash transaction or sale occurred.

Key Details

  • Transaction date: 2026-06-23; Form 4 filed: 2026-06-24 (timely).
  • Grant: 28,000 shares reported as an award/derivative (code A) at $0.00.
  • Vesting: The option vests on the earlier of (i) June 23, 2027, or (ii) the day before the next annual meeting of stockholders after June 22, 2026 (per footnote).
  • Plan/policy: Granted pursuant to the Issuer's Outside Director Compensation Policy.
  • Shares owned after transaction: Not disclosed in the provided filing.
  • Filing status: Timely (no late filing flag).

Context This is a routine director compensation option award, not an open‑market buy or sale. As a derivative award, the economic benefit depends on vesting and any future exercise terms; it does not represent immediate proceeds or a market purchase. Such grants are common for non‑executive directors and are primarily compensation, not necessarily an indicator of personal market sentiment.